古吉拉特邦Kheda地区间日疟原虫复发模式研究。

Indian journal of malariology Pub Date : 1996-12-01
H C Srivastava, S K Sharma, R M Bhatt, V P Sharma
{"title":"古吉拉特邦Kheda地区间日疟原虫复发模式研究。","authors":"H C Srivastava,&nbsp;S K Sharma,&nbsp;R M Bhatt,&nbsp;V P Sharma","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Relapse pattern in P. vivax malaria was studied in five villages of Nadiad taluka, Kheda district, Gujarat. P. vivax cases treated with 600 mg chloroquine and in combination with 50 mg pyrimethamine (adult dose) yielded 28.31 and 27.73% relapse rate respectively. While relapse rate of 5.78% was observed with five day course of 75 mg primaquine (15 mg/day) administered as radical treatment. Relapse rate in 5-10 yr of age group was comparatively more than other age groups. There was no noticeable difference in relapse rates among male and female. The short-term relapse with a lag period of 2-3 months was significantly higher in this area. The longest relapse with an interval of 17 months was found in one case treated with chloroquine along with pyrimethamine. However, primaquine regimen prevented consecutive relapses. Primaquine has been found adequate to prevent relapse in more than 90% vivax cases, while efficacy of chloroquine-pyrimethamine and chloroquine alone was almost comparable. A high proportion of relapse may be minimized, if 5-days radical treatment is given at appropriate time.</p>","PeriodicalId":77174,"journal":{"name":"Indian journal of malariology","volume":"33 4","pages":"173-9"},"PeriodicalIF":0.0000,"publicationDate":"1996-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.\",\"authors\":\"H C Srivastava,&nbsp;S K Sharma,&nbsp;R M Bhatt,&nbsp;V P Sharma\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Relapse pattern in P. vivax malaria was studied in five villages of Nadiad taluka, Kheda district, Gujarat. P. vivax cases treated with 600 mg chloroquine and in combination with 50 mg pyrimethamine (adult dose) yielded 28.31 and 27.73% relapse rate respectively. While relapse rate of 5.78% was observed with five day course of 75 mg primaquine (15 mg/day) administered as radical treatment. Relapse rate in 5-10 yr of age group was comparatively more than other age groups. There was no noticeable difference in relapse rates among male and female. The short-term relapse with a lag period of 2-3 months was significantly higher in this area. The longest relapse with an interval of 17 months was found in one case treated with chloroquine along with pyrimethamine. However, primaquine regimen prevented consecutive relapses. Primaquine has been found adequate to prevent relapse in more than 90% vivax cases, while efficacy of chloroquine-pyrimethamine and chloroquine alone was almost comparable. A high proportion of relapse may be minimized, if 5-days radical treatment is given at appropriate time.</p>\",\"PeriodicalId\":77174,\"journal\":{\"name\":\"Indian journal of malariology\",\"volume\":\"33 4\",\"pages\":\"173-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian journal of malariology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of malariology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

研究了古吉拉特邦Kheda区Nadiad taluka五个村庄间日疟的复发模式。氯喹600 mg和乙胺嘧啶50 mg(成人剂量)治疗间日疟复发率分别为28.31%和27.73%。以柏氨喹75 mg (15 mg/d)作为根治性治疗5 d,复发率为5.78%。5 ~ 10岁年龄组复发率高于其他年龄组。男性和女性的复发率无明显差异。该地区短期复发率较高,滞后期为2-3个月。在氯喹与乙胺嘧啶联合治疗的1例中,复发时间最长,间隔为17个月。然而,伯氨喹方案防止连续复发。已发现伯氨喹足以防止90%以上的间日疟病例复发,而氯喹-乙胺嘧啶和单独使用氯喹的疗效几乎相当。如果在适当的时间给予5天的根治性治疗,复发率可以降到最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.

Relapse pattern in P. vivax malaria was studied in five villages of Nadiad taluka, Kheda district, Gujarat. P. vivax cases treated with 600 mg chloroquine and in combination with 50 mg pyrimethamine (adult dose) yielded 28.31 and 27.73% relapse rate respectively. While relapse rate of 5.78% was observed with five day course of 75 mg primaquine (15 mg/day) administered as radical treatment. Relapse rate in 5-10 yr of age group was comparatively more than other age groups. There was no noticeable difference in relapse rates among male and female. The short-term relapse with a lag period of 2-3 months was significantly higher in this area. The longest relapse with an interval of 17 months was found in one case treated with chloroquine along with pyrimethamine. However, primaquine regimen prevented consecutive relapses. Primaquine has been found adequate to prevent relapse in more than 90% vivax cases, while efficacy of chloroquine-pyrimethamine and chloroquine alone was almost comparable. A high proportion of relapse may be minimized, if 5-days radical treatment is given at appropriate time.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信